Clinical trials: Tobacco Smoking in Depressed Patients
Tobacco Smoking in Depressed Patients
Smoking Cessation And Reduction in Depression
It is well established in studies across several countries that tobacco smoking is more prevalent among depressed patients than the general population.
- Trial name
- scarid (NCT02124187)
- Testing
- Ecig 24 mg nicotine, Ecig 0 mg nicotine, Nicotine free inhalator
- Where
- Italy
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Catania
Smoking Cessation, Depression
Efficacy of Exercise and Counseling Intervention on Relapse in Smoker With Depressive Disorders
This study investigated the efficacy of an exercise and counseling intervention for depressed smokers (depression subscale of the Hospital Anxiety and Depression Scale, HADS-D score ≥ 8) in term of likelihood of smoking…
- Trial name
- STOB-ACTIV (NCT01401569)
- Testing
- Exercise and counseling (for smoking cessation and physical activity)
- Where
- France
- Volunteers
- 70 people
- Sponsor
- University Hospital, Montpellier
Smoking, Bipolar Disorder
Varenicline in Bipolar Depressed Patients
Patients with bipolar disorder have one of the highest rates of nicotine dependence and one of the lowest quit rates. Varenicline has been shown in previous trials to be effective for smoking cessation, but has not been studied…
- Conditions
- Smoking, Bipolar Disorder, Depression
- Trial name
- Varenicline (NCT00813800)
- Testing
- Varenicline
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- Mark Frye